News

Xelafaslatide is a small-molecule Fas inhibitor designed to protect key retinal cells, including photoreceptors, from cell death.

An effective but underused resource with positive benefits for patients with myopia.

The eye care providers authored an opinion article that has been published in "The Ocular Surface."

Diana Canto-Sims, OD, and Nancy Gries, export sales manager at Logoproject Eyewear, discuss profit margins in creating a private label eyewear brand.

ODs are in a prime position to identify exploited victims.

VR technology captures not only visual fields but a full “stack” of pretest results.

Catch up on the top stories in optometry during the week of December 1-December 5.

Under the terms of the agreement, Iolyx Therapeutics has granted Théa exclusive worldwide development and commercialization rights, excluding Asia, to ILYX-002 for the treatment of ocular surface diseases.

HUC1-394 is a peptide-based eye drop for dry eyes being developed by the company.

Most active ingredients in presbyopia-correcting eye drops, including pilocarpine, aceclidine, and carbachol, are direct-acting cholinergic agonists that activate the iris sphincter muscle, causing pupil constriction.

The survey was conducted by OnePoll on October 2025 and included 1000 US patients with dry eye.

This is the first submission for approval under the exclusive license and commercialization agreement for South Korea that was signed between LENZ and Lotus.

Cyclosporine ophthalmic emulsion 0.05% is a topical immunomodulator to increase tear production in patients whose tear production is thought to be reduced due to ocular inflammation associated with dry eye syndrome.

Travis LeFevre, founder of LFVR Eyewear, and Diana Canto-Sims, OD, discuss the process of creating a private label eyewear brand with the company.

This year's conference brought eye care professionals insights, tips, and pearls.

Sleep plays a pivotal role in maintaining ocular health.

Mark Graham of Your Brand Eyewear shares his company's success stories regarding creating private label eyewear for practices.

Researchers performed a secondary analysis of the DREAM study data.

Rachon, OD, FAAO, DipABO, makes the most of her optometric education through her work with residents and advocacy efforts.

Outlining the benefits of modulating the gut microbiome in diabetes.

Mark Graham of Your Brand Eyewear and Diana Canto-Sims, OD, also discuss the importance of looping in your staff when creating your own eyewear brand.

Our patients benefit from a preventive approach that includes lifestyle adjustment, nutrition, and supplementation.

Brieann Adair, OD, discusses popular opinion among patients regarding contact lens wear.

Additionally, the FDA approved a monthly dosing option for some patients who may benefit from resuming this schedule across approved indications.

Adair, OD, outlines the vast expanse of possibilities that lenses offer patients outside of refractive error.

Diana Canto-Sims, OD, and Mark Graham of Your Brand Eyewear discuss the benefits of starting your own eyewear brand and how to get started with the company.

Dye, OD, details exciting new trials for amblyopia that are in the works at NYU Langone Eye Center.

Maturing of the vestibulo-ocular reflex is independent of sensory input.